Corbus Pharmaceuticals Holdings, Inc.

CRBP · Nasdaq · SIC 2834: Pharmaceutical Preparations
260
SEC Filings

Business Summary

All references in this report to Corbus, the Company, we, us, or our mean Corbus Pharmaceuticals Holdings, Inc. and its subsidiaries unless we state otherwise, or the context otherwise indicates. Overview Corbus Pharmaceuticals Holdings, Inc. (the Company or Corbus) is a clinical stage company focused on promising new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways. Cor...

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCRBPdiscussed_in_filing Healthcare & Bio
topic_mentionCRBPdiscussed_in_filing Healthcare & Bio
topic_mentionCRBPdiscussed_in_filing Healthcare & Bio
topic_mentionCRBPdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-098530EDGAR71K words
2025-03-112024-12-310000950170-25-037335EDGAR—
2024-03-122023-12-310000950170-24-030133EDGAR—
2023-03-072022-12-310000950170-23-006469EDGAR—
2022-03-082021-12-310000950170-22-003145EDGAR—
2021-03-152020-12-310001493152-21-006016EDGAR—
2020-03-162019-12-310001493152-20-004077EDGAR—
2019-03-122018-12-310001493152-19-003143EDGAR—
2018-03-122017-12-310001493152-18-003208EDGAR—
2017-03-082016-12-310001493152-17-002256EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277748EDGAR19K words
2025-08-052025-06-300000950170-25-103118EDGAR—
2025-05-062025-03-310000950170-25-064507EDGAR—
2024-11-072024-09-300000950170-24-123486EDGAR—
2024-08-062024-06-300000950170-24-091922EDGAR—
2024-05-072024-03-310000950170-24-054625EDGAR—
2023-11-072023-09-300000950170-23-060377EDGAR—
2023-08-082023-06-300000950170-23-039960EDGAR—
2023-05-092023-03-310000950170-23-019825EDGAR—
2022-11-082022-09-300000950170-22-023282EDGAR—
2022-08-092022-06-300000950170-22-016150EDGAR—
2022-05-102022-03-310000950170-22-009050EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001193125-26-097582EDGAR2K words
2026-02-250001193125-26-068566EDGAR—
2026-01-120001193125-26-009758EDGAR—
2025-12-180001193125-25-324796EDGAR—
2025-12-110001193125-25-315039EDGAR—
2025-11-120001193125-25-276062EDGAR—
2025-11-030001193125-25-261722EDGAR—
2025-10-300001193125-25-258692EDGAR—
2025-10-200001193125-25-243046EDGAR—
2025-09-160001193125-25-204389EDGAR—

260 total filings indexed. 228 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001595097
TickerCRBP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d1e08d49b16fb72fa8c1f27491044091f47da5ecc7fef9fce9b3eeec2c99e9b5
parent: 1d17bc92b3f7ab78bae327cbf6ce02d1f10ad791b6f9c184a50f93a0ab4a678d
content hash: b017fa837b475d5094a116faf0346f8a40489dffcd1294da54860a88968a6cec
signed: 2026-04-13T04:44:28.719Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf